Lv32
300 积分 2024-03-19 加入
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
2个月前
已完结
Linker Substitution Influences Succinimide Ring Hydrolysis Equilibrium Impacting Stability of Attachment to the Antibody-Drug Conjugate
10个月前
已完结
Strategies for UF/DF-Based Impurity Removal in the Post-conjugation Purification of Antibody–Drug Conjugates
11个月前
已完结
Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry
11个月前
已完结
Considerations for Starting Material Designation for Drug-Linkers in Antibody–Drug Conjugates
11个月前
已完结
皖公网安备34019202002308
